1	Lymphocyte	Lymphocyte	_	_	_	_	_	_	_
2	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
3	receptor	receptor	_	_	_	_	_	_	_
4	:	:	_	_	_	_	_	_	_
5	predictor	predictor	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	sertraline	sertraline	_	_	_	_	_	_	_
8	response	response	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	adolescent	adolescent	_	_	_	_	_	_	_
11	major	major	_	_	_	_	_	_	_
12	depressive	depressive	_	_	_	_	_	_	_
13	disorder	disorder	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	MDD	MDD	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Major	major	_	_	_	_	_	_	_
2	depressive	depressive	_	_	_	_	_	_	_
3	disorder	disorder	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	MDD	MDD	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	adolescents	adolescent	_	_	_	_	_	_	_
9	demonstrates	demonstrate	_	_	_	_	_	_	_
10	resistance	resistance	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	tricyclic	tricyclic	_	_	_	_	_	_	_
13	antidepressants	antidepressant	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	absence	absence	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	hypercortisolemia	hypercortisolemia	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	efficacy	efficacy	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	serotonin	serotonin	_	_	_	_	_	_	_
5	reuptake	reuptake	_	_	_	_	_	_	_
6	inhibitors	inhibitor	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	SRIs	SRI	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	uncertain	uncertain	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	response	response	_	_	_	_	_	_	_
15	predictors	predictor	_	_	_	_	_	_	_
16	are	be	_	_	_	_	_	_	_
17	unavailable	unavailable	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Abnormal	abnormal	_	_	_	_	_	_	_
2	fast	fast	_	_	_	_	_	_	_
3	feedback	feedback	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	negative	negative	_	_	_	_	_	_	_
6	feedback	feedback	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	hypothalamic-pituitary-adrenal	hypothalamic-pituitary-adrenal	_	_	_	_	_	_	_
10	axis	axis	_	_	_	_	_	_	_
11	implicates	implicate	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	dampened	dampened	_	_	_	_	_	_	_
14	limbic-hippocampal	limbic-hippocampal	_	_	_	_	_	_	_
15	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
16	type	type	_	_	_	_	_	_	_
17	II	ii	_	_	_	_	_	_	_
18	receptor	receptor	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	GCII	GCII	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	hypothesized	hypothesize	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	lymphocyte	lymphocyte	_	_	_	_	_	_	_
5	GCII	GCII	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	altered	alter	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	adolescent	adolescent	_	_	_	_	_	_	_
10	MDD	MDD	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	could	could	_	_	_	_	_	_	_
13	serve	serve	_	_	_	_	_	_	_
14	as	as	_	_	_	_	_	_	_
15	a	a	_	_	_	_	_	_	_
16	marker	marker	_	_	_	_	_	_	_
17	for	for	_	_	_	_	_	_	_
18	response	response	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	SRIs	sri	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	an	an	_	_	_	_	_	_	_
3	open-label	open-label	_	_	_	_	_	_	_
4	study	study	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	adolescents	adolescent	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	n	n	_	_	_	_	_	_	_
9	=	=	_	_	_	_	_	_	_
10	20	20	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	meeting	meet	_	_	_	_	_	_	_
13	DSM-III-R	dsm-iii-r	_	_	_	_	_	_	_
14	criteria	criterion	_	_	_	_	_	_	_
15	for	for	_	_	_	_	_	_	_
16	MDD	MDD	_	_	_	_	_	_	_
17	showed	show	_	_	_	_	_	_	_
18	baseline	baseline	_	_	_	_	_	_	_
19	lymphocyte	lymphocyte	_	_	_	_	_	_	_
20	GCII	GCII	_	_	_	_	_	_	_
21	sites	site	_	_	_	_	_	_	_
22	per	per	_	_	_	_	_	_	_
23	cell	cell	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	sites/cell	sites/cell	_	_	_	_	_	_	_
26	)	)	_	_	_	_	_	_	_
27	values	value	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	793	793	_	_	_	_	_	_	_
30	+/-	+/-	_	_	_	_	_	_	_
31	106	106	_	_	_	_	_	_	_
32	versus	versus	_	_	_	_	_	_	_
33	2,563	2,563	_	_	_	_	_	_	_
34	+/-	+/-	_	_	_	_	_	_	_
35	499	499	_	_	_	_	_	_	_
36	(	(	_	_	_	_	_	_	_
37	+/-	+/-	_	_	_	_	_	_	_
38	SEM	SEM	_	_	_	_	_	_	_
39	)	)	_	_	_	_	_	_	_
40	for	for	_	_	_	_	_	_	_
41	matched	match	_	_	_	_	_	_	_
42	controls	control	_	_	_	_	_	_	_
43	(	(	_	_	_	_	_	_	_
44	n	n	_	_	_	_	_	_	_
45	=	=	_	_	_	_	_	_	_
46	18	18	_	_	_	_	_	_	_
47	)	)	_	_	_	_	_	_	_
48	(	(	_	_	_	_	_	_	_
49	t	t	_	_	_	_	_	_	_
50	=	=	_	_	_	_	_	_	_
51	3.5	3.5	_	_	_	_	_	_	_
52	;	;	_	_	_	_	_	_	_
53	df	df	_	_	_	_	_	_	_
54	=	=	_	_	_	_	_	_	_
55	36	36	_	_	_	_	_	_	_
56	;	;	_	_	_	_	_	_	_
57	p	p	_	_	_	_	_	_	_
58	<	<	_	_	_	_	_	_	_
59	.001	.001	_	_	_	_	_	_	_
60	)	)	_	_	_	_	_	_	_
61	.	.	_	_	_	_	_	_	_

1	GCII	GCII	_	_	_	_	_	_	_
2	was	be	_	_	_	_	_	_	_
3	bimodally	bimodally	_	_	_	_	_	_	_
4	distributed	distribute	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	with	with	_	_	_	_	_	_	_
7	SRI	SRI	_	_	_	_	_	_	_
8	responders	responder	_	_	_	_	_	_	_
9	differing	differ	_	_	_	_	_	_	_
10	from	from	_	_	_	_	_	_	_
11	nonresponders	nonresponder	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	t	t	_	_	_	_	_	_	_
14	=	=	_	_	_	_	_	_	_
15	3.9	3.9	_	_	_	_	_	_	_
16	;	;	_	_	_	_	_	_	_
17	df	df	_	_	_	_	_	_	_
18	=	=	_	_	_	_	_	_	_
19	14	14	_	_	_	_	_	_	_
20	;	;	_	_	_	_	_	_	_
21	p	p	_	_	_	_	_	_	_
22	<	<	_	_	_	_	_	_	_
23	.001	.001	_	_	_	_	_	_	_
24	)	)	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	GCII	GCII	_	_	_	_	_	_	_
2	accurately	accurately	_	_	_	_	_	_	_
3	classified	classify	_	_	_	_	_	_	_
4	90	90	_	_	_	_	_	_	_
5	percent	percent	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	sertraline	sertraline	_	_	_	_	_	_	_
8	responders	responder	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	80	80	_	_	_	_	_	_	_
11	percent	percent	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	nonresponders	nonresponder	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Only	only	_	_	_	_	_	_	_
2	SRI	SRI	_	_	_	_	_	_	_
3	responders	responder	_	_	_	_	_	_	_
4	showed	show	_	_	_	_	_	_	_
5	GCII	GCII	_	_	_	_	_	_	_
6	sites/cell	sites/cell	_	_	_	_	_	_	_
7	upregulated	upregulate	_	_	_	_	_	_	_
8	after	after	_	_	_	_	_	_	_
9	6	6	_	_	_	_	_	_	_
10	weeks	week	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	treatment	treatment	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	t	t	_	_	_	_	_	_	_
15	=	=	_	_	_	_	_	_	_
16	2.1	2.1	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	df	df	_	_	_	_	_	_	_
19	=	=	_	_	_	_	_	_	_
20	10	10	_	_	_	_	_	_	_
21	;	;	_	_	_	_	_	_	_
22	p	p	_	_	_	_	_	_	_
23	<	<	_	_	_	_	_	_	_
24	.05	.05	_	_	_	_	_	_	_
25	)	)	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

